â– LECTURE OVERVIEW: Nephrotic Syndrome represents a severe pattern of glomerular injury characterized by a dramatic increase in glomerular capillary wall permeability to plasma proteins.
â– PATHOPHYSIOLOGIC MECHANISMS:
1. Podocyte Foot Process Effacement: Glomerular basement membrane filtration barriers are disrupted, commonly due to podocyte injury or antigen complex deposition.
2. Massive Proteinuria: Loss of negative charge barriers causes massive, heavy proteinuria (>3.5 grams/24 hours).
3. Hypoalbuminemia: Hepatic protein synthesis cannot compensate for renal losses, dropping serum albumin below 3 g/dL.
4. Oncotic Pressure Loss: Lower intravascular oncotic pressure shifts fluid into the interstitium, triggering compensatory sodium retention that causes generalized edema (anasarca).
5. Hyperlipidemia: In response to hypoalbuminemia, the liver non-specifically upregulates lipoprotein synthesis, leading to hyperlipidemia and lipiduri (visible on microscopy as 'fatty casts' and maltese-cross lipid droplets).
â– BIOCHEMICAL MECHANISMS:
At the molecular level, enzyme kinetics govern reaction rates. Competitive inhibitors raise apparent Michaelis constants without changing maximum speed, whereas noncompetitive inhibitors decrease maximum speed directly.
â– MOLECULAR PATHWAY DYNAMICS:
Intracellular cascades undergo profound modifications, altering secondary transcription levels and receptor presentation on cellular membranes.
[HY-BOARD-1070]
🌟 Dynamic Clinical Key:
Urinary protein wasting is not limited to albumin. Wasting of Antithrombin-III (ATIII) creates a hypercoagulable state that carries a high risk of thromboembolism, particularly renal vein thrombosis, which presents as sudden flank pain and hematuria. Focus on rate-limiting regulatory steps for pharmacological design. Therapeutic molecules targeting upstream signaling components demonstrate superior efficacy profiles.